Recent advances in interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors and PROTACs
Yifan Feng(Shanxi Medical University), Tiantai Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hai‐Yu Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Qingyang Zhang(First Affiliated Hospital of Zhengzhou University), Chengjuan Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Anqi Shao(Columbia University)
Cited by 2
Related Papers
Angiopoietin1/TIE2 and VEGF/FLK1 Induced by MSC Treatment Amplifies Angiogenesis and Vascular Stabilization after Stroke
|Journal of Cerebral Blood Flow & Metabolism|2007|302
Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001–2018
|Cardiovascular Diabetology|2024|188
IntraLase Femtosecond Laser vs Mechanical Microkeratomes in LASIK for Myopia: A Systematic Review and Meta-analysis
|Journal of Refractive Surgery|2012|155
A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs
|Bioorganic & Medicinal Chemistry|2019|136
Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity
|Bioorganic Chemistry|2018|132